Addex Therapeutics (ADXN) Revenue & Revenue Breakdown
Addex Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.61M
Latest Revenue (Q)
$235.00K
Main Segment (Y)
Research
Addex Therapeutics Revenue by Period
Addex Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.61M | 13.39% |
| 2022-12-31 | $1.42M | -51.22% |
| 2021-12-31 | $2.92M | -19.28% |
| 2020-12-31 | $3.61M | 30.77% |
| 2019-12-31 | $2.76M | -54.29% |
| 2018-12-31 | $6.04M | 100.00% |
| 2017-12-31 | - | -100.00% |
| 2016-12-31 | $17.33K | -57.00% |
| 2015-12-31 | $40.30K | -52.81% |
| 2014-12-31 | $85.40K | -6.93% |
| 2013-12-31 | $91.76K | 100.00% |
| 2012-12-31 | - | -100.00% |
| 2011-12-31 | $2.82M | 42.94% |
| 2010-12-31 | $1.98M | -51.71% |
| 2009-12-31 | $4.09M | -84.74% |
| 2008-12-31 | $26.81M | 5405.28% |
| 2007-12-31 | $486.93K | -89.72% |
| 2006-12-31 | $4.74M | - |
Addex Therapeutics generated $1.61M in revenue during NA 2023, up 13.39% compared to the previous quarter, and up 26.69% compared to the same period a year ago.
Addex Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $235.00K | 53.14% |
| 2023-12-31 | $153.45K | -53.18% |
| 2023-09-30 | $327.73K | -48.05% |
| 2023-06-30 | $630.88K | 25.95% |
| 2023-03-31 | $500.89K | -15.45% |
| 2022-12-31 | $592.43K | 44.70% |
| 2022-09-30 | $409.42K | 123.29% |
| 2022-06-30 | $183.35K | -22.71% |
| 2022-03-31 | $237.24K | -40.32% |
| 2021-12-31 | $397.49K | -41.72% |
| 2021-09-30 | $682.00K | -31.29% |
| 2021-06-30 | $992.60K | 17.57% |
| 2021-03-31 | $844.22K | -53.63% |
| 2020-12-31 | $1.82M | 6578.04% |
| 2020-09-30 | $27.26K | -96.83% |
| 2020-06-30 | $860.79K | -4.79% |
| 2020-03-31 | $904.06K | -13.09% |
| 2019-12-31 | $1.04M | 107.06% |
| 2019-09-30 | $502.36K | -3.29% |
| 2019-06-30 | $519.43K | -25.89% |
| 2019-03-31 | $700.87K | 4.98% |
| 2018-12-31 | $667.61K | -0.00% |
| 2018-09-30 | $667.61K | -75.12% |
| 2018-06-30 | $2.68M | - |
| 2018-03-31 | $2.68M | 1865.16% |
| 2017-12-31 | $136.56K | - |
| 2017-09-30 | $136.56K | 20.45% |
| 2017-06-30 | $113.38K | - |
| 2017-03-31 | $113.38K | 76.81% |
| 2016-12-31 | $64.13K | - |
| 2016-09-30 | $64.13K | -54.76% |
| 2016-06-30 | $141.75K | - |
| 2016-03-31 | $141.75K | - |
Addex Therapeutics generated $235.00K in revenue during Q1 2024, up 53.14% compared to the previous quarter, and up 39.67% compared to the same period a year ago.
Addex Therapeutics Revenue Breakdown
Addex Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Research | $1.60M | $1.40M | $2.90M | - | - |
| Ifrs Research | - | - | - | $3.60M | $2.80M |
Addex Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Research (100.00%).
Addex Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IPHA | Innate Pharma | $51.90M | $16.56M |
| KRON | Kronos Bio | $6.29M | $2.69M |
| DYAI | Dyadic | $2.90M | $334.62K |
| ADXN | Addex Therapeutics | $1.61M | $235.00K |
| SNGX | Soligenix | $839.36K | $2.34K |
| ACHL | Achilles Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
| ERYP | PHAXIAM Therapeutics | - | - |
| ATXI | Avenue Therapeutics | - | - |
| CYCN | Cyclerion Therapeutics | - | - |
ADXN Revenue FAQ
What is Addex Therapeutics’s yearly revenue?
Addex Therapeutics's yearly revenue for 2023 was $1.61M, representing an increase of 13.39% compared to 2022. The company's yearly revenue for 2022 was $1.42M, representing a decrease of -51.22% compared to 2021. ADXN's yearly revenue for 2021 was $2.92M, representing a decrease of -19.28% compared to 2020.
What is Addex Therapeutics’s quarterly revenue?
Addex Therapeutics's quarterly revenue for Q1 2024 was $235K, a 53.14% increase from the previous quarter (Q4 2023), and a -53.08% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $153.45K, a -53.18% decrease from the previous quarter (Q3 2023), and a -74.10% decrease year-over-year (Q4 2022). ADXN's quarterly revenue for Q3 2023 was $327.73K, a -48.05% decrease from the previous quarter (Q2 2023), and a -19.95% decrease year-over-year (Q3 2022).
What is Addex Therapeutics’s revenue growth rate?
Addex Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -44.69%, and for the last 5 years (2019-2023) was -41.62%.
What are Addex Therapeutics’s revenue streams?
Addex Therapeutics's revenue streams in c 23 are Research
What is Addex Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Addex Therapeutics was Research. This segment made a revenue of $1.6M, representing 100.00% of the company's total revenue.